149 related articles for article (PubMed ID: 9798992)
1. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM
Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
[TBL] [Abstract][Full Text] [Related]
2. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
3. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
[TBL] [Abstract][Full Text] [Related]
4. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
[TBL] [Abstract][Full Text] [Related]
6. Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma.
Alban S
Semin Thromb Hemost; 2001 Oct; 27(5):503-11. PubMed ID: 11668420
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells.
Horie S; Hiraishi S; Hirata Y; Kazama M; Matsuda J
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):277-85. PubMed ID: 11085919
[TBL] [Abstract][Full Text] [Related]
8. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
Brodin E; Iversen N; Hansen JB
J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
[TBL] [Abstract][Full Text] [Related]
9. Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitor.
Ellery PE; Hardy K; Oostryck R; Adams MJ
Clin Appl Thromb Hemost; 2008 Jul; 14(3):267-78. PubMed ID: 18160611
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.
Sato N; Kokame K; Miyata T; Kato H
Thromb Haemost; 1998 Jan; 79(1):217-21. PubMed ID: 9459350
[TBL] [Abstract][Full Text] [Related]
11. Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium.
Kostovski E; Dahm AE; Iversen N; Hjeltnes N; Østerud B; Sandset PM; Iversen PO
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):254-9. PubMed ID: 21297449
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor production by human mesangial cells in culture.
Yamabe H; Osawa H; Inuma H; Kaizuka M; Tamura N; Tsunoda S; Fujita Y; Shirato K; Onodera K
Thromb Haemost; 1996 Aug; 76(2):215-9. PubMed ID: 8865534
[TBL] [Abstract][Full Text] [Related]
13. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
[TBL] [Abstract][Full Text] [Related]
14. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
15. Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man.
Hansen JB; Sandset PM; Huseby KR; Huseby NE; Nordøy A
Thromb Haemost; 1996 Nov; 76(5):703-9. PubMed ID: 8950777
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
Chabut D; Fischer AM; Colliec-Jouault S; Laurendeau I; Matou S; Le Bonniec B; Helley D
Mol Pharmacol; 2003 Sep; 64(3):696-702. PubMed ID: 12920206
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration.
Cella G; Cipriani A; Tommasini A; Rampin E; Sbarai A; Rocconi R; Mazzaro G; Luzzatto G
Semin Thromb Hemost; 1997; 23(1):45-9. PubMed ID: 9156410
[TBL] [Abstract][Full Text] [Related]
18. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
Warn-Cramer BJ; Almus FE; Rapaport SI
Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
[TBL] [Abstract][Full Text] [Related]
20. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
Nagase H; Enjyoji K; Kamikubo Y; Kitazato KT; Kitazato K; Saito H; Kato H
Thromb Haemost; 1997 Aug; 78(2):864-70. PubMed ID: 9268186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
